Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexmedetomidine Doses in Spinal Anesthesia
NCT07051512Phase 1Completed
- Sponsor
- Tanta University
- Start
- Jul 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Tanta University. Primary endpoint: Safe intrathecal dexmedetomidine dose at 2 hours. Started Jul 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07051512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07051512.